$28B pharma deal, Bill Marriott interview: The National Observer Dec. 13, 2022
December 13, 2022 at 11:13 AM EST
Amgen Inc. has reached a $28 billion deal to acquire Horizon Therapeutics PLC. Amgen has slimmed down its own operations but remained an opportunistic acquirer.
